Article content
My column for this week was all set in my mind; I was going to criticize LifeLabs for the long lines and long waits for those requiring blood work. But before I pumped a word into this computer I happened to see on television even longer lines of people waiting outside in freezing temperatures to receive their first COVID-19 vaccinations. The Canadian Press reported that dozens of residents of Richmond Hill aged 80 and older lined up outside the Richmond Green Sports Centre in the cold, paperwork in hand for their immunization appointments. Many were leaning on walkers or sitting in wheelchairs, bundled up against the -8 C weather.
After what should have been a major sigh of relief, a Newmarket resident is instead left feeling outraged after his 80-year-old grandma was forced to wait outdoors in freezing temperatures for her COVID-19 vaccination appointment on Thursday.
A Newmarket, Ont. resident is outraged after his 80-year-old grandma was forced to wait outdoors in freezing temperatures for her COVID-19 vaccination appointment on Thursday.
A Newmarket, Ont. resident is outraged after his 80-year-old grandma was forced to wait outdoors in freezing temperatures for her COVID-19 vaccination appointment on Thursday.
Medtronic Announces First Procedures in Pivotal Trial to Evaluate Novel Ablation Technology in Treating Atrial Fibrillation
Study Will Determine the Safety and Effectiveness of Pulsed Electrical Fields to Interrupt Irregular Heart Rhythms Medtronic plc the global leader in medical technology, today announced the first procedures in the investigational device exemption pivotal trial to evaluate the PulseSelect ™ Pulsed Field Ablation System, a novel, breakthrough technology that uses pulsed electric fields to treat atrial fibrillation . … Study Will Determine the Safety and Effectiveness of Pulsed Electrical Fields to Interrupt Irregular Heart Rhythms
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the first procedures in the investigational device exemption (IDE) pivotal trial to evaluate the PulseSelect ™ Pulsed Field Ablation (PFA) System, a novel, breakthrough technology that uses pulsed electric fields to treat atrial fibrillation (A